Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Scanning electrochemical microscopy of individual catalytic nanoparticles.

Sun T, Yu Y, Zacher BJ, Mirkin MV.

Angew Chem Int Ed Engl. 2014 Dec 15;53(51):14120-3. doi: 10.1002/anie.201408408. Epub 2014 Oct 21.

PMID:
25332196
2.

Hepatitis B virus DNA quantification with the three-in-one (3io) method allows accurate single-step differentiation of total HBV DNA and cccDNA in biopsy-size liver samples.

Taranta A, Tien Sy B, Zacher BJ, Rogalska-Taranta M, Manns MP, Bock CT, Wursthorn K.

J Clin Virol. 2014 Aug;60(4):354-60. doi: 10.1016/j.jcv.2014.04.015. Epub 2014 May 2.

PMID:
24890819
3.

Increased HEV seroprevalence in patients with autoimmune hepatitis.

Pischke S, Gisa A, Suneetha PV, Wiegand SB, Taubert R, Schlue J, Wursthorn K, Bantel H, Raupach R, Bremer B, Zacher BJ, Schmidt RE, Manns MP, Rifai K, Witte T, Wedemeyer H.

PLoS One. 2014 Jan 21;9(1):e85330. doi: 10.1371/journal.pone.0085330. eCollection 2014.

4.

Improved immune status corresponds with long-term decline of quantitative serum hepatitis B surface antigen in HBV/HIV co-infected patients.

Arendt E, Jaroszewicz J, Rockstroh J, Meyer-Olson D, Zacher BJ, Mederacke I, Manns MP, Wedemeyer H, Cornberg M, Wursthorn K.

Viral Immunol. 2012 Dec;25(6):442-7. doi: 10.1089/vim.2012.0036. Epub 2012 Nov 6.

PMID:
23131018
5.

HBeAg-positive hepatitis delta: virological patterns and clinical long-term outcome.

Heidrich B, Serrano BC, Idilman R, Kabaçam G, Bremer B, Raupach R, Önder FO, Deterding K, Zacher BJ, Taranta A, Bozkaya H, Zachou K, Tillmann HL, Bozdayi AM, Manns MP, Yurdaydın C, Wedemeyer H.

Liver Int. 2012 Oct;32(9):1415-25. doi: 10.1111/j.1478-3231.2012.02831.x. Epub 2012 Jun 20.

PMID:
22716112
6.

Ectopic expression of murine CD47 minimizes macrophage rejection of human hepatocyte xenografts in immunodeficient mice.

Waern JM, Yuan Q, Rüdrich U, Becker PD, Schulze K, Strick-Marchand H, Huntington ND, Zacher BJ, Wursthorn K, DiSanto JP, Guzman CA, Manns MP, Ott M, Bock M.

Hepatology. 2012 Oct;56(4):1479-88. doi: 10.1002/hep.25816.

PMID:
22535707
7.

Multicenter evaluation of the Elecsys hepatitis B surface antigen quantitative assay.

Zacher BJ, Moriconi F, Bowden S, Hammond R, Louisirirotchanakul S, Phisalprapa P, Tanwandee T, Wursthorn K, Brunetto MR, Wedemeyer H, Bonino F.

Clin Vaccine Immunol. 2011 Nov;18(11):1943-50. doi: 10.1128/CVI.05122-11. Epub 2011 Aug 31.

8.

Rapid early HDV RNA decline in the peripheral blood but prolonged intrahepatic hepatitis delta antigen persistence after liver transplantation.

Mederacke I, Filmann N, Yurdaydin C, Bremer B, Puls F, Zacher BJ, Heidrich B, Tillmann HL, Rosenau J, Bock CT, Savas B, Helfritz F, Lehner F, Strassburg CP, Klempnauer J, Wursthorn K, Lehmann U, Manns MP, Herrmann E, Wedemeyer H.

J Hepatol. 2012 Jan;56(1):115-22. doi: 10.1016/j.jhep.2011.06.016. Epub 2011 Jul 14.

PMID:
21762665
9.

Correlation between the Elecsys HBsAg II assay and the Architect assay for the quantification of hepatitis B surface antigen (HBsAg) in the serum.

Wursthorn K, Jaroszewicz J, Zacher BJ, Darnedde M, Raupach R, Mederacke I, Cornberg M, Manns MP, Wedemeyer H.

J Clin Virol. 2011 Apr;50(4):292-6. doi: 10.1016/j.jcv.2010.12.008. Epub 2011 Jan 26.

PMID:
21273117
10.

Development of a protocol for the quantitative determination of HBeAg using the Elecsys® HBeAg immunoassay.

Wursthorn K, Zacher BJ, Jaroszewicz J, Darnedde M, Manns M, Wedemeyer H.

J Viral Hepat. 2011 Jul;18(7):e179-83. doi: 10.1111/j.1365-2893.2010.01419.x. Epub 2010 Dec 30.

PMID:
21199189

Supplemental Content

Loading ...
Support Center